This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
BNY Mellon & Deutsche Bank Jointly Develop Digital FX Solution
by Zacks Equity Research
BNY Mellon (BK) and Deutsche Bank's (DB) alliance to develop a digital FX solution will likely reduce the transaction times in trading of emerging market restricted currencies.
Top Stock Reports for Walmart, BHP & IBM
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Walmart (WMT), BHP Group (BHP) and International Business Machines (IBM).
Investment Banking to Aid Banks in Q2 Amid Coronavirus-Led Turmoil
by Zacks Equity Research
Though M&As have taken a hit in the second quarter amid the coronavirus outbreak-related economic slowdown, improving underwriting activities are likely to aid top-line growth of investment banks.
Morgan Stanley to Maintain Dividend Amid Coronavirus Woes
by Zacks Equity Research
Supported by a strong liquidity position, Morgan Stanley (MS) seems well-poised to be able to maintain its current dividend payment in the near term even if the economic situation worsens.
Why are Bank Stocks Rallying Today?
by Madeleine Johnson
Shares of big banks are surging on Thursday after U.S. banking regulators decided to loosen restrictions on the Volcker Rule, which is part of the 2010 Dodd-Frank Act.
Schwab (SCHW) Closes Deal to Acquire Certain Assets of Motif
by Zacks Equity Research
The acquisition of certain assets of Motif is likely to improve Schwab's (SCHW) market share and support revenues.
JPMorgan Gets Nod to Own 100% Stake in China-based Futures JV
by Zacks Equity Research
JPMorgan's (JPM) efforts to increase stake in China JVs are likely to support revenues and improve market share.
Wells Fargo Partners With iCapital, To Sell Feeder Fund Platform
by Zacks Equity Research
Wells Fargo's (WFC) partnership with FinTech firm iCapital is aimed at providing best-in-class solution to its clients with innovative alternative investments.
The Zacks Analyst Blog Highlights: Merck, CVS Health, Morgan Stanley, Applied Materials and Enterprise Products Partners
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Merck, CVS Health, Morgan Stanley, Applied Materials and Enterprise Products Partners
Robinhood, Sports Bettors and the Recent Myth About Volatility
by David Borun
Millennials and bored gamblers have been blamed for recent volatility, but the numbers don't add up.
Top Stock Reports for Merck, CVS & Morgan Stanley
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Merck (MRK), CVS Health (CVS) and Morgan Stanley (MS).
Goldman Sachs BDC (GSBD) Amends & Restates Merger Agreement
by Zacks Equity Research
Goldman Sachs BDC (GSBD) amends and restates its merger agreement dated Dec 9, 2019, with Goldman Sachs Middle Market Lending Corp.
Banks Issue Mixed Views for Q2, Reserves Likely to Rise
by Priti Dhanuka
Big banks -- Wells Fargo (WFC), Citigroup (C), Morgan Stanley (MS), U.S. Bancorp (USB) and JPMorgan (JPM) -- announce Q2 guidance.
Morgan Stanley (MS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Morgan Stanley (MS) closed at $49.53 in the latest trading session, marking a +1.73% move from the prior day.
Restructuring & Buyouts Aid Morgan Stanley (MS), Costs High
by Zacks Equity Research
Morgan Stanley's (MS) restructuring efforts and strategic buyouts are likely to aid its financials. However, rising operating expenses and near-zero interest rates are headwinds.
Schwab-Ameritrade Deal Gets DOJ & Shareholder Nod, Stocks Up
by Zacks Equity Research
Schwab's (SCHW) all-stock deal to acquire TD Ameritrade (AMTD) overcomes major hurdles as the DOJ and shareholders of both the companies give their approval.
Citigroup (C) Plans to Build Its Strategic Advisory Team
by Zacks Equity Research
Citigroup (C) plans to merge its data capabilities with insights to advise clients on shareholder activism.
Morgan Stanley in Talks to Acquire CLO Assets of Assurant
by Zacks Equity Research
Morgan Stanley (MS) is in talks to buy the CLO assets of Assurant.
Credit Suisse (CS) to Own 51% Stake in China Securities JV
by Zacks Equity Research
Credit Suisse (CS) to raise ownership stake in Credit Suisse Founder Securities (CSFS) following the removal of Chinese regulators' restrictions on the ownership of local venture partners.
Morgan Stanley (MS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Morgan Stanley (MS) closed the most recent trading day at $44.20, moving -0.45% from the previous trading session.
Big Banks in Murky Waters, Plea for Claim Dismissal Annulled
by Priti Dhanuka
Big global banks in trouble again, with the annulment of their plea regarding the dismissal of claims, per a lawsuit alleging the financial firms for rigging prices in the foreign-exchange market.
HSBC Intends to Acquire Remaining Stake of German Division
by Zacks Equity Research
HSBC Holdings (HSBC) poised to take control of German unit by buying the remaining stake.
Morgan Stanley (MS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Morgan Stanley (MS) closed at $40.13 in the latest trading session, marking a -0.42% move from the prior day.
Morgan Stanley to Launch a Wealth Management Unit in Canada
by Zacks Equity Research
Morgan Stanley (MS) to strengthen presence in Canada by establishing a new unit dedicated to service employees and executives in the country.
Morgan Stanley (MS) Down 2.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Morgan Stanley (MS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.